Medication errors related to product names.
Confusion arising from product naming practices can result in unauthorized drug and improper dose/quantity errors. Efforts by FDA, drug manufacturers, pharmacists, other health care professionals, and patients can reduce the risk of these errors.
Santell
John P
JP
Educational Program Initiatives, United States Pharmacopeia (USP) Center for the Advancement of Patient Safety, Rockville, Maryland, USA. jps@usp.org
Cousins
Diane D
DD
D003221:Confusion; D003657:Decision Making; D004348:Drug Labeling; D006801:Humans; D008508:Medication Errors / Q000517:prevention & control*; D004364:Pharmaceutical Preparations; D014481:United States
D004364:Pharmaceutical Preparations